Literature DB >> 2915572

Effects of simultaneous and sequential exposure to granulocytic and monocytic inducers on the choice of differentiation pathway in HL-60 promyelocytic leukemia cells.

S Zinzar1, T Ohnuma, J F Holland.   

Abstract

HL-60 promyelocytic leukemic cells were induced to differentiate by the combination of two alternative inducers: phorbol-12-myristate 13-acetate (PMA) and either dimethyl sulfoxide (DMSO) or retinoic acid (RA). Simultaneous exposure to optimal concentrations of PMA and either DMSO or RA potentiated PMA-induced differentiation into monocyte-macrophages. Granulocytic inducers combined with lower concentration of PMA competed with the latter for the differentiation pathway, producing monocyte-macrophages, granulocytes, paramyeloid and giant multinucleated cells. Lineage specificity of cells treated sequentially with two discrete exposures to alternative inducers depended on the order of exposure. The first exposure initiated differentiation into the pathway specific for the inducer used. The second exposure determined lineage specificity and stimulated terminal differentiation. Thus, treatment with RA for 24-72 h followed by PMA resulted in monocyte-macrophage differentiation; reversed order of exposure resulted in granulocytic differentiation. The switch in the differentiation pathway occurred at the relatively advanced stages of differentiation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2915572     DOI: 10.1016/0145-2126(89)90027-1

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Luminol and diazoluminomelanin as indicators of HL-60 cell differentiation.

Authors:  J G Bruno; J L Kiel
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-09       Impact factor: 2.416

2.  Phenotypic and functional analysis of HL-60 cells used in opsonophagocytic-killing assay for Streptococcus pneumoniae.

Authors:  Kyung-Hyo Kim; Ju Young Seoh; Su Jin Cho
Journal:  J Korean Med Sci       Date:  2015-01-21       Impact factor: 2.153

3.  Retinoic acid therapy resistance progresses from unilineage to bilineage in HL-60 leukemic blasts.

Authors:  Holly A Jensen; Rodica P Bunaciu; Christopher N Ibabao; Rebecca Myers; Jeffrey D Varner; Andrew Yen
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.